McGuire Capital Advisors’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$818 Hold
25
﹤0.01% 789
2026
Q1
$884 Hold
25
﹤0.01% 731
2025
Q4
$1.01K Buy
+25
New +$1.09K ﹤0.01% 788

Other funds holding CNMD

McGuire Capital Advisors's CNMD Position: Q2 2026 in Review

McGuire Capital Advisors held its CONMED (CNMD) position steady in Q2 2026 at 25 shares worth $818. The position accounts for ﹤0.01% of the portfolio, ranked #789.

McGuire Capital Advisors first reported a position in CNMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.01K in Q4 2025. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • McGuire Capital Advisors held 25 shares of CONMED worth $818 as of Q2 2026.
  • McGuire Capital Advisors left its CONMED share count unchanged in Q2 2026.
  • CONMED made up ﹤0.01% of McGuire Capital Advisors's portfolio in Q2 2026, its #789 holding.
  • McGuire Capital Advisors first reported a position in CONMED in Q4 2025 and has held it in 3 quarters since.
  • McGuire Capital Advisors's CONMED position peaked at $1.01K in Q4 2025.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on McGuire Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.